Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more Biosimilars: Herzuma launched in Europe, FDA rejects Sandoz rituximab. Mundipharm has launched Herzuma, its biosimilar version of Roche’s Herceptin trastuzumab in Europe. ... This follows hot on the heels of MSD (working with Samsung Bioepsis) that

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer alongside its older HER2 drug Herceptin (trastuzumab). ... The company is positioning Perjeta as a successor to HER2 stalwart Herceptin - which is starting to feel the effects of biosimilar competition - and approval for adjuvant use is another step

Ocrevus helps Roche stave off biosimilar threat

Ocrevus helps Roche stave off biosimilar threat stable sales for cancer antibodies Herceptin (trastuzumab) and Avastin (bevacizumab) - has given Roche the confidence to raise its annual sales and earnings forecasts for 2018. ... The accelerating decline reveals Roche’s vulnerability as biosimilars

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more from blockbusters Avastin, Herceptin and Mabthera/Rituxan.

ViiV’s two-drug HIV combo backed by CHMP

ViiV’s two-drug HIV combo backed by CHMP CHMP meeting round-up. Among other highlights the CHMP backed two biosimilar medicines - Amgen’s Kanjinti version of Roche’s Herceptin (trastuzumab) for the treatment of breast and gastric cancer and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics